Dutch Consortium for Healthcare Evaluation in Obstetrics and Gynaecology NVOG Consortium
Onze patienten-website over de onderzoeken: www.watverwachtu.nl.
Login for members:
Name:
Password:
Create new
 Agenda
You can find us on twitter, facebook and LinkedIn. Download the 'Zakkaartjes'-app!

               
Please send updates about your studies for our facebook, twitter, linkedin and consortium website.
 


Consortium News 2014



23-dec-2014 The Apostel IV trial has stopped recruiting. The Board of the NVOG Consortium 2.0 has decided to stop the Apostel IV trial because of new evidence regarding the use of Nifedipine in PPROM. For more information see: www.studies-obsgyn.nl/apostel4

 

18-dec-2014 New study added: PEOPLE. The PEOPLE study is designed to compare the effectiveness and cost-effectiveness of pessary versus surgery as initial treatment for moderateto severe symptomatic pelvic organ prolapse in women at two year after initiation of treatment. See PEOPLE website for more details.


11-dec-2014 New study added: Stop or Go? Stop or Go? Relapse prevention training with guided tapering of antidepressants during pregnancy. The study answers to the urgent need for evidence from randomized studies to make rational decisions regarding continuation or tapering of SSRIs during pregnancy. See Stop or Go? website for more details.


20-oct-2014 Consortium day 28th of November. This year's consortium day will take place on the 28th of November at the LUMC. You can sign up here till the 28th of October. See program consortium day for more detailed information. We hope to see you all on the 28th at the LUMC!

 

16-oct-2014 New study added: The Dutch STRIDER. The Dutch STRIDER is a nationwide randomized controlled trial which aims to eveluate the effectiveness of sildenafil (versus placebo) in achieving healthy perinatal survival in severe, early-onset fetal growth restriction due to placental insufficiency. All information can be found on http://www.studies-obsgyn.nl/STRIDER.


10-oct-2014 Consortium 2.0 at SMFM 2015! Five oral and fifteen poster presentations will be presented at the SMFM 2015 in San Diego. The researchers of the Lifestyle study have the honour to present their results in the plenary session. Click here to see a full list of the oral and poster presentations. Congratulations to all for these wonderful results!

 

07-oct-2014 The H2Olie study has completed its inclusions. The H2Olie study aims to determine whether at HSG the use of oil-based contrast media results in higher ongoing pregnancy and live birth rates compared to the use of water-based contrast media. Many thanks to all those involved! See H2Olie website for more details.

 

06-oct-2014 The PIMPP study has completed its inclusions. The PIMPP study aims to evaluate the implementation of cervical pessaries in women with multiple pregnancy and cervical length below 38 mm in daily practice. Many thanks to all those involved! See PIMPP website for more details.

 

03-oct-2014 Consortium day 28th of November. This year's consortium day will take place on the 28th of November at the LUMC. See program consortium day for more detailed information. You can sign up here. We hope to see you all on the 28th at the LUMC!

 

30-jul-2014 The MISOREST study has completed its inclusions. The MISOREST study aims to compare effectiveness and costs between curettage and expectant management in symptom free women with sonographic evidence of incomplete evacuation of a miscarriage after primary misoprostol treatment. Many thanks to all those involved! See MISOREST website for more details.

 

30-jul-2014 The Apostel III study has completed its inclusions. The Apostel III study aims to assess the effectiveness of the tocolytic agents Nifedipine versus Atosiban in the improvement of neonatal outcome in women with threatened preterm labour. Many thanks to all those involved! See Apostel III website for more details.

 

19-june-2014 A short film (3 minutes) was made about the Consortium, when we were nominated for the Porter prize by the Value Based HealthCare Center Europe (which we did not win, but we do have the film!) You can watch the film here.

 

30-apr-2014 This Sunday, May 4th, NVOG Consortium vice-chairman Sjoerd Repping will appear in the TV-show Buitenhof. He will discuss the need for evaluation of healthcare in order to improve quality and reduce health care costs.  He will be joined by Arno Rutte (member of parliament for VVD) and Roger van Boxtel (CEO at Menzis Health Insurance).

Click here to watch full show, interview starts at 16:10.
Buitenhof is on Dutch tv, sunday may 4th, 12:10 p.m. Nederland 1.

 

25-apr-2014 The WoMan study has completed its inclusions! The urogynaecology WoMan trial studies the effectiveness of Word catheter and Marsupialization
in treatment of cyst or abcess of the Bartholin gland.
Many thanks to all those involved! See the WoMan Trial website for more details.

 

25-apr-2014 The INDEX trial has reached the 900th inclusion mark! The trial is now halfway. Thanks to everyone involved in making this possible. See the INDEX website for more information.

 

04-apr-2014 Solomon study in THE LANCET! Congratulations to all those involved! Femke Slaghekke, et al for the Solomon study group.
Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial. Click here for the full text. We thank the gynaecologists and research nurses from the participating hospitals for their dedication and assistance, and we are grateful to all the women who participated in the trial.

 

02-apr-2014 New url Oracle Clinical: please use this link to reach Oracle Clinical.

https://cru-oc.amc.nl/olsa/oc/rdcLogin.do?event=doSetup&db=pilot1.amc.nl&mode=P

 

31-mar-2014 New study added: TeMpOH-3. The TeMpOH-3 study is a nationwide retrospective cohort study which aims to assess the effect of prophylactic radiological interventions on the occurrence of major obstetric haemorrhage, transfusion requirements, maternal morbidity and mortality in patients at risk of abnormally invasive placenta. All information can be found on http://www.studies-obsgyn.nl/TeMpOH-3.

 

31-mar-2014 The OPTIMIST study has completed its inclusions. The OPTIMIST study aims to assess the cost-effectiveness of routine use of ovarian reserve tests (ORTs) and subsequent use of individualised FSH dosages in predicted poor and hyper responders as compared to a policy without ORT using standard dosages of FSH. Many thanks to all those involved! See OPTIMIST website for more details.

 

31-mar-2014 New studie added: IRIS. The IRIS study fulfils the urgent need to evaluate the value of third trimester US for monitoring foetal growth among low risk women in primary care. If shown to be effective, routine third trimester US will contribute to reducing the national perinatal mortality and severe morbidity rate.

 

28-mar-2014 Oracle Clinical out of order on march 31 and april 1. Due to maintenance Oracle Clinical can not be used on march 31 and april 1.

 

27-mar-2014 HysNiche article in AD! To raise awareness among women the HysNiche study group published an article in the newspaper AD. This publication was featured on many news sites and was also discussed on the evening news (NOS and RTL).
For full text click here.

 

13-mar-2014 New study added: AID. The AID-study evaluates whether IUI without the addition of ovarian hyperstimulation gives comparable pregnancy rates compared to ICI in women who start with artificial insemination with donor sperm in terms of effectiveness and costs. All information can be found on www.studies-obsgyn.nl/AID-study.

 

10-mar-2014 The need for evaluation research in the Volkskrant! Not all treatments have been proven to be effective in clinical research and medical specialist have expressed the need for large research looking at the effectiveness of these interventions. Click here for the fulltext.

 

10-mar-2014 Two major prizes for Hypitat II at SMFM 2014! Congratulations to Kim Broekhuijsen and the Hypitat II study group for the Norman F. Gant award for best research and the award for the best oral presentation at SMFM 2014.

 

24-feb-2014 6 applications are through to the next round for a ZonMw grant! Congratulations to all those involved. For a list of all first round grant approvals and the declarations of intent, please click here.


03-feb-2014 
ESEP study in THE LANCET! Congratulations to all those involved! Femke Mol, et al for the ESEP study group. Salpingotomy versus salpingectomy in women with tubal pregnancy. Click here for the full text. We thank the gynaecologists and research nurses from the participating hospitals for their dedication and assistance, and we are grateful to all the women who participated in the trial.


31-jan-2014 WOMB trial in BJOG! Congratulations to all those involved! Prick et al.  Transfusion policy after severe postpartum haemorrhage. Click here for the fulltext.


27-jan-2014 Oracle Clinical out of order on January 27. Due to maintenance Oracle Clinical can not be used on January 27 between 18:00 and 23:00 h.


17-jan-2014 New study added: PC. The PC study evaluates whether cervical pessary can replace cervical cerclage in women with previous preterm birth and a short cervix and in women who are considered for a primary cerclage in terms of effectiveness and costs. All information can be found on www.studies-obsgyn.nl/pc.


3-jan-2014 Oracle Clinical out of order on January 6. Due to maintenance Oracle Clinical can not be used on January 6 between 18:00 and 22:00 h.